印度和特拉华州建立了生物制造联盟,以推进负担得起的疫苗、清洁能源和AI驱动的创新。 India and Delaware forge biomanufacturing alliance to advance affordable vaccines, clean energy, and AI-driven innovation.

印度和特拉华州正在推进生物制造、制药和清洁能源方面的战略伙伴关系,欧盟部长Jitendra Singh博士提议成立一个联合工作组,以促进研究、启动联系和劳动力培训方面的合作。 India and Delaware are advancing a strategic partnership in biomanufacturing, pharmaceuticals, and clean energy, with Union Minister Dr Jitendra Singh proposing a joint working group to boost collaboration in research, startup linkages, and workforce training. 这项倡议突显了印度在可负担的生物制剂和疫苗生产方面的作用, 支持强大的创新生态系统, 包括CSIR的37个实验室和1万亿卢比的基金. The initiative highlights India’s growing role in affordable biologics and vaccine production, supported by a strong innovation ecosystem including CSIR’s 37 labs and a Rs 1 lakh crore fund. 特拉华州的生物科学遗产、制造基地和商业环境补充了印度的能力,双方都侧重于AI驱动的进程、绿色氢和监管科学。 Delaware’s bioscience legacy, manufacturing base, and business environment complement India’s capabilities, with both sides focusing on AI-driven processes, green hydrogen, and regulatory science.